@Pilbars For my way of thinking the next 12 months are key here.......they are moving rather rapidly in terms of bio-techs, and they are still the only company (afaik) that are running clinical based CBD trials in the dermatology space, they still have that first mover advantage.........
Shame you're out but don't let it bug you too much if you can..........follow your system and back your own choices 100% and don't be swayed. Its the only way to play this imo.You can sure hop back in any time your sentiment shifts, that's the beauty of the investment roundabout.
Bot is pretty much a set and forget play for my way of thinking (at least until full phase 2 data hits the airwaves......I do watch it every day having said that, but I trade/invest for a living so occupational hazard I guess)........I'm in the red at current levels certainly.......but overall I'm not significantly worried (but that's just me). Like everyone here I'd like to see some significant confident buying over bot.......market is a funny often illogical place as I'm sure your aware.......
Antibiotic resistant skin infection treatment possibilities, acne, AD, and psoriasis all shaping as very promising going on the available published data...........but of course only time will tell.
Key factors as to why I'm still confidentially holding here are two fold.......the prior data sets they have released........and the fact they are FULLY FUNDED for the two phase 2 trials and for progressing and development of their other pipeline products........this second point is very significant imo.........if they weren't fully funded to progress their business for approx the next 12 months then my attitude would certainly be a lot more cautious.
As to leaky ship syndrome.............who knows..........but that 7News clip they dropped sure showed one happy patient..........placebo or not
CBD is a very interesting compound with some exciting possible applications.......early clinical work done by bot suggests nothing to sway my opinion as to it's efficacy in treating a wide range of problems especially for derma based applications when coupled with Permetrex........that's my two bob hope it might help.
Have a good weekend.
- Forums
- ASX - By Stock
- Ann: Botanix Presents at Fall Clinical Dermatology Conference
@Pilbars For my way of thinking the next 12 months are key...
-
- There are more pages in this discussion • 103 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
(20min delay)
|
|||||
Last
36.0¢ |
Change
-0.005(1.37%) |
Mkt cap ! $707.4M |
Open | High | Low | Value | Volume |
36.5¢ | 37.0¢ | 36.0¢ | $391.8K | 1.080M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 160000 | 35.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
36.0¢ | 11013 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
11 | 423267 | 0.105 |
23 | 1189777 | 0.100 |
1 | 10111 | 0.099 |
1 | 50000 | 0.098 |
1 | 50000 | 0.097 |
Price($) | Vol. | No. |
---|---|---|
0.110 | 555657 | 10 |
0.115 | 560304 | 6 |
0.120 | 829451 | 14 |
0.125 | 1083838 | 12 |
0.130 | 498290 | 12 |
Last trade - 16.10pm 29/11/2024 (20 minute delay) ? |
BOT (ASX) Chart |